Global emergence of nosocomial gram-negative pathogens possessing carbapenem-hydrolyzing β-lactamases

Journal of Biological Sciences

Volumn 6, Issue 3, 2006, Pages 434-445

  Bratu, Simona ^a   Quale, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

lactamases; Antibiotics; Carbapenemase

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; TAZOBACTAM; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; UNINDEXED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG EFFICACY; DRUG HYDROLYSIS; ENZYME ACTIVITY; EUROPE; FAR EAST; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SOUTHERN EUROPE; UNITED STATES;

ACINETOBACTER BAUMANNII; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 33745736372     PISSN: 17273048     EISSN: 18125719     Source Type: Journal    
DOI: 10.3923/jbs.2006.434.445     Document Type: Article

References (103)

1. Afzal-Shah, M., N. Woodford and D.M Livermore, 2001. Characterization of OXA-25, OXA-26 and OXA-27, molecular class D β-lactamases associates with carbapenem-resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother., 45: 583-588.
2. Afzal-Shah, M., H.E. Villar and D.M. Livermore, 1999. Biochemical characteristics of a carbapenemase from Acinetobacter baumannii isolates collected in Buenos Aires, Argentina. J. Antimicrob. Chemother., 43: 127-131.
3. Appleman, M.D., H. Belzberg, D.M. Citron, P.N.R. Heseltine, A.E. Yellin, J. Murray and T.V. Berne, 2000. In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolates during an intensive care unit outbreak. Antimicrob. Agents Chemother., 44: 1035-1040.
4. Arakawa, Y., N. Shibata, K. Shibayama, H. Kurokawa, T. Yagi, H. Fugiwara and M. Goto, 2000. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thio compounds. J. Clin Microbiol., 38: 40-43.
5. Avison, M.B., C.S. Higgins, C.J. yon Heldreich, P.M. Bennett and T.R. Walsh, 2001. Plasmid location and molecular heterogeneity of the L1 and L2 beta-lactamase genes of Stenotrophomonas maltophilia. Antimicrob. Agents Chemother., 45: 413-4195.
6. Basen, W., P. Desmery, S. Ilutovich and A. Di Martino, 2000. Intrathecal use of colistin. J. Clin. Microbiol., 38: 3523.
7. Berlana D., J.M. Llop, M.B. Badia and R. Jodar, 2005. Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am. J. Health-Syst. Pharm., 62: 39-47.
8. Bonnet, R., H. Marchandin, C. Chanal, D. Sirot, R. Labia, C. De Champs, E. Jumas-Bilak and J. Sirot, 2002. Chromosome-encoded class D beta-lactamase OXA-23 in Proteus mirabilis. Antimicrob. Agents Chemother., 46: 2004-2006.
9. Bou, G., G. Cervero, M.A. Dominguez, C. Quereda and J. Martinez-Beltran, 2000a. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamase. J. Clin. Microbiol., 38: 3299-3305.
10. Bou, G., A. Oliver and J. Martinez-Beltran, 2000b. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother., 44: 1556-1561.
11. Bradford, P.A., S. Bratu, C. Urban, M. Visalli, N. Mariano, D. Landman, J.J. Rahal, S. Brooks, S. Cebular and J. Quale, 2004. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City. Clin. Infect. Dis., 39: 55-60.
12. Bradford, P.A., C. Urban, N. Mariano, S.J. Projan, J.J. Rahal and K. Bush, 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase and the loss of an outer membrane protein. Antimicrob. Agents Chemother., 41: 563-569.
13. Bratu, S., D. Landman M. Alam, E. Tolentino and J. Quale, 2005a. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, NY. Antimicrob. Agents Chemother., 49: 776-778.
14. Bratu, S., D. Landman, R. Haag, R. Recco, A. Eramo, M. Alam and J. Quale. 2005b. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium. Arch. Intl. Med., 165: 1430-1435.
15. Bratu, S., J. Quale, S. Cebular, R. Heddurshetti and D. Landman, 2005c. Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, NY: Molecular epidemiology and in vitro activity of polymyxin. Eur. J. Clin. Microbiol. Infect. Dis., 24: 196-201.
16. Bratu, S., M. Mooty, S. Nichani, D. Landman C. Gullans, B. Pettinato, U. Karumudi, P. Tolaney and J. Quale, 2005d. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, NY: Epidemiology and recommendations for detection. Antimicrob. Agents Chemother,. 49: 3018-3020.
17. Bratu, S., P. Tolaney, U. Karamudi, J. Quale, M. Mooty, S. Nichani and D. Landman, 2005e. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: Molecular epidemiology and in-vitro activity of polymyxin B and other agents. J. Antimicrob. Chemother., 56: 128-132.
18. Brown, S., C. Bantar, H.-K. Young and S.G.B.Amyes, 1998. Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2. Lancet, 351: 186-187.
19. Cao, V.T.B., G. Arlet, B.M. Ericsson, A. Tammelin, P. Courvalin and T. Lambert, 2000. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J. Antimicrob. Chemother., 46: 895-900.
20. GIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob. Agents Chemother., 48: 4654-4661.
21. Chow, J.W. and D.M. Shlaes, 1991. Imipenem resistance associated with the loss of a 40 kDa outer membrane protein in Enterobacter aerogenes. J Antimicrob Chemother., 28: 499-504.
22. Chu, Y.W., M. Afzal-Shah, E.T.S. Houang, M-F.I. Palepou, D.J. Lyon, N. Woodford and D. Livermore, 2001. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother., 45: 710-714.
23. Corbella, X., A. Montero, M. Pujol, M.A. Dominguez, J. Ayats, M.J. Argerich, F. Garrigosa, J. Ariza and F. Gudiol, 2000. Emergence and rapid spread of Carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J. Clin. Microbiol., 38: 4086-4095.
24. Cornaglia, G., A. Mazzariol, L. Lauretti, G.M. Rossolini and R. Fontana, 2000. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin. Infect. Dis., 31: 1119-1125.
25. Cornaglia, G., M.L. Riccio, A. Mazariol, L. Lauretti, R. Fontana and G.M. Rossolini, 1999. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet, 353: 899-900.
26. Dalla-Costa, L.M., J.M. Coelho, H.A.P.H.M. Souza, M.E.S. Castro, C.J.N. Stier, K.L. Bragagnolo, A. Rea-Neto, S.R. Penteado-Filho, D.M. Livermore and Neil Woodford, 2003. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J. Clin. Microbiol., 41: 3403-3406.
27. Donald, H.M., W. Scaife, S.G.B. Amyes and H-K. Young, 2000. Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother., 44: 196-199.
28. Fernandex-Viladrich, P., X. Corbella, L. Corral, F. Tubau and A. Mateu, 1999. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin. Infect. Dis., 28: 916-917.
29. Gales, A.C., R.N. Jones, K.R. Forward, J. Linares, H.S. Sader and J.Verhoef, 2001. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiologic features and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin. Infect. Dis., 32: 104-113.
30. Garnacho-Montero, J., C. Ortiz-Leyba, F.J. Jimenez-Jimenez, A.E. Barrero-Almodovar, J.L. Garcia-Garmendia, M. Bernabeu-Wittell, S.L. Gallego-Lara and J. Madrazo-Osuna, 2003. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP. Clin. Infect. Dis., 36: 1111-1118.
31. IMP-7Antimicrob. Agents Chemother., 46: 255-258.
32. Go, E.S., C. Urban, J. Burns, B. Kreiswirth, W. Eisner, N. Mariano, K. Mosinka-Snipas and J.J. Rahal, 1994. Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet, 344:1329-1332.
33. Hamer, D.H., 2000. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am. J. Respir. Crit. Care Med., 162: 328-330.
34. Heritier, C., A. Dubouix, L. Poirel, N. Marty and P. Nordmann, 2005. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. J. Antimicrob. Chemother., 55:115-118.
35. Heritier, C., L. Poirel, D. Aubert and P. Nordmann, 2003. Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob. Agents Chemother., 47: 268-273.
36. IMP. Antimicrob. Agents Chemother., 42: 2006-2011.
37. Hogg, G.M., J.G. Barr and C.H. Webb, 1998. In vitro activity of the combination of colistin and rifampicin against multidrug-resistant strains of Acinetobacter baumannii. J. Antimicrob. Chemother., 41: 494-495.
38. Hong, T., E.S. Moland, B. Abdalhamid, N.D. Hanson, J. Wang, C. Sloan, D. Fabian, A. Farajallah, J. Levine and K. S. Thomson, 2005. Escherichia coli: Development of carbapenem resistance during therapy. Clin. Infect. Dis., 40: 84-86.
39. Hossain, A., M.J. Ferraro, R.M. Pino, R.B. Dew, III, E.S. Moland, T.J. Lockhart, K.S. Thomson, R.V. Goering and N.D. Hanson, 2004. Plasmid-mediated carbapenem hydrolyzing enzyme KPC-2 in Enterobacter sp. Antimicrob. Agents Chemother., 48: 4438-4440.
40. IMP among clinically isolated strains of Serratia marcescens. Antimicrob. Agents Chemother., 39: 824-829.
41. Jimenez-Mejias, M.E., J. Pachon, B. Becerril, J. Palomino-Nicas, A. Rodriguez-Cobacho and M. Revuelta, 1997. Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/ sulbactam. Clin. Infect. Dis., 24: 932-935.
42. Jones, R.N., L.M. Desphande, J.M. Bell, J.D. Turnidge, S. Kohno, Y. Hirakata, Y. Ono, Y. Miyazawa, S. Kawakama, M. Inoue, Y. Hirata, M.A. Toleman, 2004. Evaluation of the contemporary occurrence rates of metallo-β-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002). Diagn. Microbiol. Infect. Dis., 49: 289-294.
43. Koh, T.H., L.H. Sng, G.S. Babini, N. Woodford, D.M. Livermore and L.M.C. Hall, 2002. Carbapenem-resistant Klebsiella pneumoniae in Singapore producing IMP-1 β-lactamase and lacking an outer membrane protein. Antimicrob. Agents Chemother., 45: 1939-1940.
44. Kurokawa, H., T. Yagi, N. Shibata, K. Shibayama and Y. Arakawa, 1999. Worldwide proliferation of carbapenem-resistant gram-negative bacteria. Lancet, 354: 955.
45. Lagatolla, C., E.A., C. Tonin, L. Monti-Bragadin, Dolzani, F. Gombac, C. Bearzi, E. Edalucci, F. Gionechetti and G.M. Rossolini, 2004. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-β-lactamase determinants in European Hospitals. Emerg. Infect. Dis., 10: 535-538.
46. Landman, D., S. Bratu, M. Alam and J. Quale, 2005. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.J. Antimicrob. Chemother., 55: 954-957.
47. Landman, D., J.M. Quale, D. Mayorga, A. Adedeji, K. Vangala, J. Ravishankar, C. Flore and S. Brooks, 2002. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY. The preantibiotic era has returned. Arch. Intern. Med., 162: 1515-1520.
48. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother., 43: 1584-1590.
49. Lee, K., G.Y. Ha, B.M. Shin, J.J. Kim, J.O. Kang, S.J. Jang, D.Y. Yong, Y. Chong and the Korean Nationwide Surveillance of Antimicrobial Resistance (KONSAR) group, 2004. Metallo-β-lactamase-producing Gram-negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance group hospitals in 2003: Continued prevalence of VIM-producing Pseudomonas spp. and increase in IMP-producing Acinetobacter spp. Diagn. Microbiol. Infect. Dis., 50: 51-58.
50. Lee, K., W.G. Lee, Y. Uh, G.Y. Ha, J. Cho and Y. Chong, 2003. Korean Nationwide Surveillance of Antimicrobial Resistance Group. VIM- and IMP- type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg. Infect. Dis., 9: 868-871.
51. Levin, A.S., A.A. Barone, J. Penco, M.V. Santos, I.S. Marinho, E.A.G. Arruda, E.I. Manrique and S.F Costa, 1999. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis., 28: 1008-1011.
52. Linden, P.K., S. Kusne, K. Coley, P. Fontes, D.J. Kramer and D. Paterson, 2003. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin. Infect. Dis., 37: 154-160.
53. Livermore, D.L., 1992. Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 36: 2046-2048.
54. Livermore, D. and N. Woodford, 2000. Carbapanemases: a problem in waiting? Curr. Opin. Microbiol., 3: 489-495.
55. Lopez-Otsoa, F., L. Gallego and K.J. Towner et al. 2002. Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain. J. Clin. Microbiol., 40: 4741-4743.
56. Manikal, V.M., D. Landman, G. Saurina, E. Oydna, H. Lal and J. Quale, 2000. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, NY: Citywide prevalence, interinstitutional spread and relation to antibiotic usage. Clin. Infect. Dis., 31: 101-106.
57. Martinez-Martinez, L., A. Pascual, S. Hernandez-Alles, D. Alvarez-Diaz, A.I. Suarez, J. Tran, V.J. Benedi and G.A. Jacoby, 1999. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother., 43: 1669-1673.
58. Miriagou, V., L.S. Tzouvelekis, S. Rossiter, E. Tzelepi, F.J. Angulo, J.M. Whichard, 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother., 47: 1297-1300.
59. Moland, E.S., N.D. Hanson, V.L. Herrera, J.A. Black, T.J. Lockhart, A. Hossain, J.J. Johnson, R.V. Goering and K.S. Thomson, 2003. Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J. Antimicrob. Chemother., 51: 711-714.
60. Montero, A., J. Ariza, X. Corbella, A. Domenech, C. Cabellos, J. Ayats, F. Tubau, C. Ardanuy and F. Gudiol, 2002. Efficacy of colistin versus β-lactams, aminoglycosides and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob. Agents Chemother., 46: 1946-1952.
61. Montero, A., J. Ariza, X. Corbella, A. Domenech, C. Cabellos, J. Ayats, F. Tubau, C. Borraz and F. Gudiol, 2004. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model. J. Antimicrob. Chemother., 54: 1085-1091.
62. Naas, T. and P. Nordmann, 1994. Analysis of a carbapenem-hydrolyzing class A β-lactamase from Enterobacter cloacae and of its LysR-type regularoty protein. Proc. Natl. Acad. Sci., 91: 7693-7697.
63. Naas, T., L. Vandel, W. Sougakoff, D.M. Livermore and P. Nordmann, 1994. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother., 38: 1262-1270.
64. Nordmann, P., S. Mariotte, T. Naas, R. Labia and M.H. Nicolas, 1993. Biochemical properties of a carbapenem-hydrolyzing β-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother., 37: 939-946.
65. Nordmann, P. and L. Poirel, 2002. Emerging carbapenemases in gram-negative aerobes. Clin. Microbiol. Infect., 8: 321-331.
66. Osana, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura and N. Kato, 1994. Molecular characterization of an enterobacterial metallo-beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother., 38: 71-78.
67. Ouderkirk, J.P., J.A. Nord, G.S. Turett and J.W. Kislak, 2003. Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant Gram-negative bacteria. Antimicrob. Agents Chemother., 47: 2659-2662.
68. Pachon-Ibanez, M.E., M.E. Jimenez-Mejias, C. Pichardo, A.C. Llanos and J. Pachon, 2004. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob. Agents Chemother., 48: 4479-4481.
69. Pai, H., J-W. Kim, J. Kim, J.H. Lee, K.W. Choe and N. Gotoh, 2001. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob. Agents Chemother., 45: 480-484.
70. Paton, R., R.S. Mikes, J. Hood and S.G.B. Amyes, 1993. ARI-1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int. J. Antimicrob. Agents, 2: 81-88.
71. Poirel, L., G.F. Weldhagen, T. Naas, C. De Champs, M.G. Dove and P. Nordmann, 2001. GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother., 45: 2598-2603.
72. Poirel, L., C. Heritier, V. Tolun and P. Nordmann, 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother., 48:15-22.
73. Poirel, L., S. Marque, C. Heritier, C. Segonds, G. Chabanon and P. Nordmann, 2005. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother., 49: 202-208.
74. Pottumarthy, S., E. Smith Moland, S. Juretschko, S.R. Swanzy, K.S. Thomson and T.R. Fritsche, 2003. NmcA carbapenem-hydrolyzing enzyme in Enterobacter cloacae in North America. Emerg. Infect. Dis., 9: 999-1002.
75. Quale, J., S. Bratu, D. Landman and R. Heddurshetti, 2003. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin. Infect. Dis., 37: 214-220.
76. Queenan, A.M., C. Torres-Viera, H.S. Gold, Y. Carmeli, G.M. Eliopoulos, R.C. Moellering, Jr., J.P. Quinn, J. Hindler, A.A. Medeiros and K. Bush, 2000. SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains. Antimicrob. Agents Chemother., 44: 3035-3039.
77. Rasmussen, B.A. and K. Bush, 1997. Carbapenem-hydrolyzing beta-lactamases. Antimicrob. Agents Chemother., 41: 223-232.
78. Rasmussen, B.A., K. Bush, D. Keeney, Y. Yang, R. Hare, C. O'Gara and A.A. Medeiros, 1996. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother., 40: 2080-2086.
79. Senda, K., Y. Arakawa, K. Nakashima, H. Ito, S. Itchiyama, K. Shimokata, N. Kato and M. Ohta, 1996. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother., 40: 349-353.
80. Sobieszczyk, M.E., E.Y. Furuya, C.M. Hay, P. Pancholi, P. Della-Latta, S.M. Hammer and C.J. Kubin, 2004. Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. J. Antimicrob. Chemother., 54: 566-569.
81. Takahashi, A., S. Yomoda, I. Kobayashi, T. Okubo, M. Tsunoda and S. Iyobe, 2000. Detection of carbapenemase-producing Acinetobacter baumanii in a hospital. J. Clin. Microbiol., 38: 526-529.
82. Toleman, M.A., A.M. Simm, T.A. Murphy, A.C. Gales, D. J. Biedenbach, R. N. Jones and T.R. Walsh, 2002. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: Report from the SENTRY Antimicrobial Surveillance Program. J. Antimicrob. Chemother., 50: 673-679.
83. VIM-7, an evolutionary distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother., 48: 329-332.
84. Toleman, M.A., D. Biedenbach, D.M.C. Bennett, R.N. Jones and T.R. Walsh, 2005. Italian metallo-β-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J. Antimicrob. Chemother., 55: 61-70.
85. Tsakris, A., S. Pournaras, N. Woodford, M-F.I. Palepou, G.S. Babini, J. Douboyas and D.M. Livermore, 2000. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. Antimicrob. Agents Chemother., 38: 1290-1292.
86. Urban, C., E. Go, N. Mariano, B.J. Berger, I. Avraham, D. Rubin and J.J. Rahal, 1993. Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J. Infect. Dis., 167: 448-451.
87. Urban, C., S. Segal-Maurer and J.J. Rahal, 2003. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin. Infect. Dis., 36: 1268-1274.
88. Walsh, T.R., A. Bolmstrom and A. Gales, 2002. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J. Clin. Microbiol., 40: 2755-2759.
89. Wolff, M., M-L. Joly-Guillou, R, Farinotti and C. Carbon, 1999. In vivo efficacies of combinations of β-lactams, β-lactamase inhibitors and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob. Agents Chemother., 43: 1406-1411.
90. Wood, G.C., S.D. Hanes, M.A. Croce, T.C. Fabian and B.A. Boucher, 2002. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia. Clin. Infect. Dis., 34: 1425-1430.
91. Wood, C.A. and A.C. Reboli, 1993. Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J. Infect. Dis., 168: 1602-1603
92. Woodford, N, M-F.I. Palepou, G.S. Babini, J. Bates and D.M. Livermore, 1998. Carbapenemase-producing Pseudomonas aeruginosa in the U.K. Lancet, 352: 546-547.
93. Woodford, N., P.M. Tierno Jr, K. Young, L. Tysall, M-F. I. Palepou, E. Ward, R.E. Painter, D.F. Suber, D. Shungu, L.L. Silver, K. Inglima, J. Kornblum and D.M. Livermore, 2004. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolying class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob. Agents Chemother., 48: 4793-4799.
94. Yan, J.J, P.R. Hsueh, W.C. Ko, K.T. Luh, S.H. Tsai, H.M. Wu J.J. Wu, 2001a. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother., 45: 2224-2228.
95. IMP-8 in a university medical center in Taiwan. J. Clin. Microbiol., 39: 4433-4439.
96. Yah, J.J., W.C. Ko, C.L. Chuang and J.J. Wu, 2002. Metallo-β-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother., 50:503-511.
97. Yan, J.J., J.J. Wu, S.H. Tsai and C.L. Chuang, 2004. Comparison of the double-disk, combined disk and E-test methods for detecting metallo-β-lactamases in Gram-negative bacilli. Diagn. Microbiol. Infect. Dis., 49: 5-11.
98. Yigit, H., A.M. Queenan, G.J. Anderson, A. Domenech-Sanchez, J.W. Biddle, C.D. Steward, S. Alberti, K. Bush and F.C. Tenover, 2001. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother., 45: 1151-1161.
99. Yigit, H., G.J. Anderson, J.W. Biddle, C.D. Steward, J.K. Rasheed, L.L. Valera, J.E. McGowen, Jr. and F.C. Tenover, 2002. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob. Agents Chemother., 46: 3817-3822.
100. Yigit, H., A.M. Queenan, J.K. Rasheed, J.W. Biddle, A. Domenech-Sanchez, S. Alberti, K. Bush and F.C. Tenover, 2003. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2. Antimicrob. Agents Chemother., 47: 3881-3889.
101. Yong, D., K. Lee, J.H. Yum, H.B. Shin, G.M. Rossolini and Y. Chong, 2002. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol., 40: 3798-3801.
102. Yoon, J., C. Urban, C. Terzian, N. Mariano and J.J. Rahal, 2004. In vitro double and triple synergistic activities of polymyxin B, imipenem and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother., 2004: 48: 753-757.
103. Yum, J.H., D. Yong, K. Lee, H.S. Kim and Y. Chong, 2002. A new integron carrying VIM-2 metallo-β-lactamase gene cassette in a Serratia marcescens isolate. Diagn. Microbiol. Infect. Dis., 42: 217-219.